Current treatment and molecular targets for axial spondyloarthritis: Evidence from randomized controlled trials.
Sen R, Caplan L. Current treatment and molecular targets for axial spondyloarthritis: Evidence from randomized controlled trials. Curr Opin Pharmacol. 2022 12; 67:102307.